Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX) launched Quest AI Companion on March 2, 2026, an AI chat feature in MyQuest that analyzes up to five years of Quest lab data to explain results, highlight trends, and help users prepare questions for clinicians.
Powered by Google’s Gemini models via a strategic Google Cloud collaboration (established March 2025), the tool operates within the HIPAA-compliant MyQuest platform and is available to adult users; it is educational and not a substitute for professional medical advice.
Positive
- Launch of Quest AI Companion available now to adult MyQuest users
- Integrates up to five years of Quest lab data for personalized trend analysis
- Strategic collaboration with Google Cloud leveraging Gemini models (established March 2025)
- Operates inside HIPAA-compliant MyQuest, avoiding public AI platforms for lab data
Negative
- Tool is educational only and not for diagnosis or treatment decisions
- User concerns about accuracy and reliability may limit adoption
- Survey cited privacy and data security as barriers despite on-platform design
Key Figures
Market Reality Check
Peers on Argus
DGX is up 0.38% while peers show mixed moves: LH +0.73%, WAT +0.14%, MTD +0.14%, PKI flat, and NTRA -1.2%. With no peers in the momentum scanner and no same-day peer headlines, the reaction appears company-specific to this AI product launch.
Previous AI Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 18 | AI collaboration | Positive | -0.6% | Announced Google Cloud generative AI collaboration to enhance data and customer experience. |
Past AI-related news saw a mildly negative reaction, suggesting prior AI announcements did not consistently drive upside.
Recent history for Quest Diagnostics shows a growing emphasis on advanced technology and AI. On Mar 18, 2025, the company announced a generative AI collaboration with Google Cloud to enhance data management and personalize customer experiences, including helping patients understand lab data. That AI news produced a -0.59% move the next day, providing a reference point for how markets have previously reacted to similar AI-focused announcements.
Historical Comparison
In the past year, DGX had 1 AI-tagged event with an average move of -0.59%. Today’s modest +0.38% gain suggests a more constructive response to this product-focused AI launch.
This announcement extends the Mar 2025 Google Cloud AI collaboration into a tangible patient-facing product, shifting from infrastructure and data initiatives toward consumer-oriented AI tools for lab result interpretation.
Regulatory & Risk Context
DGX has an effective S-3ASR automatic shelf filed on 2025-06-20, enabling the company to issue debt securities on a delayed or continuous basis under Rule 415. The filing is effective under Rule 462(e), with 0 recorded usages so far, so capacity remains unused based on the provided data.
Market Pulse Summary
This announcement introduces an AI Companion that analyzes up to five years of Quest lab data within a HIPAA-compliant portal, tying directly to the prior 2025 Google Cloud generative AI collaboration. The news highlights a shift from back-end AI infrastructure toward patient-facing tools. Investors may watch adoption trends in MyQuest usage, any follow-on partnerships, and how AI-driven services support growth alongside existing diagnostics and advanced testing businesses.
Key Terms
hipaa-compliant regulatory
reference range medical
gen ai technical
AI-generated analysis. Not financial advice.
New feature based on Google's Gemini seamlessly analyzes up to five years of personal lab data to help explain results and uncover potential health risks
Available now to all adult users of the company's secure, free patient mobile app and portal MyQuest, individuals can engage Quest AI Companion with questions about their test results and immediately receive personalized, easy-to-understand explanations, without leaving the integrated, HIPAA-compliant, MyQuest solution.
"Patients often tell us they want help simplifying and understanding their test results and what the results communicate about their health," said Nicole Antonson, vice president of digital solutions and interoperability, Quest Diagnostics. "For more than 50 years, Quest has been a trusted provider of laboratory results. Now, Quest AI Companion builds on this history and empowers patients to analyze their results and spot trends they can discuss with their healthcare provider, for smarter and simpler testing that illuminates a path to better health."
The new tool is unique because it seamlessly accesses and analyzes up to five years of an individual's lab data from Quest results reports to identify trends and patterns that may indicate health risks. As the Quest AI Companion operates within the secure MyQuest platform, individuals do not need to manually input their laboratory results into a public AI tool, avoiding concerns that may arise when sharing private health data with publicly accessible AI technologies. In addition, users can prompt the tool to define test names and medical terminology from their results reports, as well as translate the meaning of lab values, such as high, low, or within a reference range. Users can also prompt the AI Companion to assist with composing questions they can ask their healthcare provider, empowering patients to have more informed conversations with clinicians.
While the use of AI technologies is growing across the healthcare industry, recent reports suggest most individuals do not access Gen AI apps to analyze their personal health data. In a survey conducted by Quest about the use of AI, participants cited privacy and data security, alongside accuracy and reliability, as concerns about the use of AI.
"People want to understand their lab data, but not everyone feels comfortable uploading their health data to public AI platforms. Quest AI Companion empowers people to access the benefits of gen AI from a healthcare services provider they already know and trust to manage their most personal lab information," said Yuri Fesko, M.D., senior vice president and chief medical officer, Quest Diagnostics.
Powered by Google's Gemini family of models, Quest AI Companion is the result of a strategic collaboration with Google Cloud, established in March 2025. Through this relationship, Quest integrates Google Cloud's advanced AI technologies to streamline data management and improve customer experiences. The parties plan to continue to work together to aid patients and providers through innovation.
Individuals interested in Quest AI Companion can now access the service through their MyQuest account. Through MyQuest, patients can also schedule appointments, access test results and pay bills. For more information, visit MyQuest.QuestDiagnostics.com.
Quest AI Companion is a chat feature intended for individuals to analyze and understand their Quest laboratory test results with their healthcare provider. Users must be at least age 18. Quest AI Companion is not a substitute for professional medical advice or visits to a healthcare provider. Patients should continue to consult with a healthcare provider about test results and any symptoms they may be experiencing. The Quest AI Companion is for educational purposes only and not for use in the diagnosis of disease or other conditions. The information provided by this system should not be used to start, stop, or change any course of treatment unless advised by your healthcare provider.
About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-introduces-ai-companion-to-help-patients-understand-and-act-on-lab-test-results-302700483.html
SOURCE Quest Diagnostics
FAQ
What is Quest AI Companion and when did Quest Diagnostics (DGX) launch it?
How does Quest AI Companion use my lab data in MyQuest (DGX)?
Is Quest AI Companion a replacement for medical advice for Quest Diagnostics (DGX) patients?
Which AI technology powers Quest AI Companion from Quest Diagnostics (DGX)?
Who can access Quest AI Companion in MyQuest and how do I start using it (DGX)?
What privacy protections does Quest AI Companion offer for Quest Diagnostics (DGX) users?
